Release

Today’s Research Reports on Trending Tickers: Dare Bioscience and MannKind

U.S. markets rallied on Monday, after posting its worst weekly decline in two years, as President Trump unveiled details from his long awaited $200 billion infrastructure plan. The Dow Jones Industrial Average spiked 1.70 percent to close at 24,607.27, while the S&P 500 Index jumped 1.39 percent to close at 2,656.00. The Nasdaq Composite Index rose 1.56 percent to close at 6,981.96.

“It usually takes a few weeks to work through the kind of correction we had. With options contracts expiring on Friday and a day off for markets next Monday, as well as important data releases, this will be a volatile week, with a lot of intraday swings,” said J.J. Kinahan, chief strategist at TD Ameritrade, according to MarketWatch.

“We are in a period when everything is being re-evaluated. The inflation number will be the first number after a tumultuous week, so people will be paying a lot of attention to it. Though, portfolio strategies should not change just on one data point,” Kinahan said.

RDI Initiates Coverage on:

Dare Bioscience, Inc.
https://rdinvesting.com/news/?ticker=DARE

MannKind Corporation
https://rdinvesting.com/news/?ticker=MNKD

Dare Bioscience’s stock jumped 50.00% Monday, to close the day at $2.79. The stock recorded a trading volume of 8,990,198 shares, which was above its three months average volume of 41,944 shares. In the last year, Dare Bioscience’s shares have traded in a range of 1.76 – 35.80. The share price has gained 58.52% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $2.22 is below its 200-day moving average of $2.74. Shares of Dare Bioscience have gained roughly 18.48 percent in the past month and are up 28.93 percent year-to-date.

Access RDI’s Dare Bioscience, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DARE

On Monday, shares of MannKind recorded a trading volume of 6,580,686 shares, which was above the three months average volume of 3,788,108 shares. The stock ended the day 4.60% higher at 2.73. The share price has gained 307.46% from its 52 week low with a 52 week trading range of 0.67 – 6.96. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $2.58 is below its 200-day moving average of $2.67. Shares of MannKind have gained roughly 13.28 percent in the past month and are up 17.67 percent year-to-date.

Access RDI’s MannKind Corporation Research Report at:
https://rdinvesting.com/news/?ticker=MNKD

Our Actionable Research on Dare Bioscience, Inc. (NASDAQ:DARE) and MannKind Corporation (NASDAQ:MNKD) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.